IDEAS home Printed from https://ideas.repec.org/a/spr/pharme/v39y2021i10d10.1007_s40273-021-01044-3.html
   My bibliography  Save this article

Lack of Cost-Effectiveness of Preoperative Erythropoiesis-Stimulating Agents and/or Iron Therapy in Anaemic, Elective Surgery Patients: A Systematic Review and Updated Analysis

Author

Listed:
  • Bert Avau

    (Belgian Red Cross)

  • Hans Van Remoortel

    (Belgian Red Cross)

  • Jorien Laermans

    (Belgian Red Cross)

  • Geertruida Bekkering

    (Center for Evidence-Based Medicine
    Cochrane Belgium)

  • Dean Fergusson

    (Ottawa Hospital Research Institute
    University of Ottawa
    Canadian Blood Services)

  • Jørgen Georgsen

    (Odense University Hospital)

  • Paola Maria Manzini

    (University Hospital Città della Salute e della Scienza di Torino)

  • Yves Ozier

    (University Hospital of Brest)

  • Emmy De Buck

    (Belgian Red Cross
    KU Leuven)

  • Veerle Compernolle

    (Belgian Red Cross
    Ghent University)

  • Philippe Vandekerckhove

    (KU Leuven
    Belgian Red Cross)

Abstract

Objectives For anaemic elective surgery patients, current clinical practice guidelines weakly recommend the routine use of iron, but not erythrocyte-stimulating agents (ESAs), except for short-acting ESAs in major orthopaedic surgery. This recommendation is, however, not based on any cost-effectiveness studies. The aim of this research was to (1) systematically review the literature regarding cost effectiveness of preoperative iron and/or ESAs in anaemic, elective surgery patients and (2) update existing economic evaluations (EEs) with recent data. Methods Eight databases and registries were searched for EEs and randomized controlled trials (RCTs) reporting cost-effectiveness data on November 11, 2020. Data were extracted, narratively synthesized and critically appraised using the Philips reporting checklist. Pre-existing full EEs were updated with effectiveness data from a recent systematic review and current cost data. Incremental cost-effectiveness ratios were expressed as cost per (quality-adjusted) life-year [(QA)LY] gained. Results Only five studies (4 EEs and 1 RCT) were included, one on intravenous iron and four on ESAs + oral iron. The EE on intravenous iron only had an in-hospital time horizon. Therefore, cost effectiveness of preoperative iron remains uncertain. The three EEs on ESAs had a lifetime time horizon, but reported cost per (QA)LY gained of 20–65 million (GBP or CAD). Updating these analyses with current data confirmed ESAs to have a cost per (QA)LY gained of 3.5–120 million (GBP or CAD). Conclusions Cost effectiveness of preoperative iron is unproven, whereas routine preoperative ESA therapy cannot be considered cost effective in elective surgery, based on the limited available data. Future guidelines should reflect these findings.

Suggested Citation

  • Bert Avau & Hans Van Remoortel & Jorien Laermans & Geertruida Bekkering & Dean Fergusson & Jørgen Georgsen & Paola Maria Manzini & Yves Ozier & Emmy De Buck & Veerle Compernolle & Philippe Vandekerckh, 2021. "Lack of Cost-Effectiveness of Preoperative Erythropoiesis-Stimulating Agents and/or Iron Therapy in Anaemic, Elective Surgery Patients: A Systematic Review and Updated Analysis," PharmacoEconomics, Springer, vol. 39(10), pages 1123-1139, October.
  • Handle: RePEc:spr:pharme:v:39:y:2021:i:10:d:10.1007_s40273-021-01044-3
    DOI: 10.1007/s40273-021-01044-3
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40273-021-01044-3
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s40273-021-01044-3?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Kevin M. Trentino & Hamish Mace & Axel Hofmann, 2022. "Preoperative Intravenous Iron for Iron Deficiency is Cost-Effective Prior to Major Elective Surgery," PharmacoEconomics, Springer, vol. 40(1), pages 133-135, January.
    2. Bert Avau & Hans Van Remoortel & Emmy De Buck & Veerle Compernolle & Philippe Vandekerckhove, 2022. "Authors’ Response to “Preoperative Intravenous Iron for Iron Deficiency is Cost-Effective Prior to Major Elective Surgery”," PharmacoEconomics, Springer, vol. 40(1), pages 137-138, January.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:39:y:2021:i:10:d:10.1007_s40273-021-01044-3. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.